Skip to main content
. 2023 Apr 18;381:e073435. doi: 10.1136/bmj-2022-073435

Fig 1.

Fig 1

Study flow diagram. IMRD=IQVIA Medical Research Data. *Participants could enter the study cohort a maximum of twice: first with an oral bisphosphonate and second when initiating denosumab. †Matched with replacement (also see method section in the supplemental file)